Compounds > n-(3-(aminomethyl)benzyl)acetamidine

n-(3-(aminomethyl)benzyl)acetamidine and alpha-synuclein

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with alpha-synuclein in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, HM; Hong, JS; Kam, W; Wilson, B; Zhang, F; Zhou, H	1

Other Studies

1 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and alpha-synuclein

Article	Year
Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. Environmental health perspectives, 2011, Volume: 119, Issue:6 Topics: alpha-Synuclein; Amidines; Animals; Animals, Genetically Modified; Benzylamines; Disease Models, Animal; Injections, Intraperitoneal; Lewy Bodies; Lipopolysaccharides; Mice; NADPH Oxidases; Nerve Degeneration; Neurodegenerative Diseases; Nitric Oxide Synthase Type II; Onium Compounds; Oxidative Stress; Parkinson Disease; Substantia Nigra	2011

Article

Year

Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.

Environmental health perspectives, 2011, Volume: 119, Issue:6

Topics: alpha-Synuclein; Amidines; Animals; Animals, Genetically Modified; Benzylamines; Disease Models, Animal; Injections, Intraperitoneal; Lewy Bodies; Lipopolysaccharides; Mice; NADPH Oxidases; Nerve Degeneration; Neurodegenerative Diseases; Nitric Oxide Synthase Type II; Onium Compounds; Oxidative Stress; Parkinson Disease; Substantia Nigra

2011